SJRES 51 is a joint resolution that would disapprove a proposed U.S. military sale to Egypt, specifically targeting four missile launch systems and related support equipment. It would block the sale under the Arms Export Control Act by requiring congressional disapproval of the defense articles and services detailed in a transmittal document submitted to Congress on May 26, 2022. If enacted, it would prevent the transfer of these defense items to the Egyptian government.
This joint resolution (SJRES 50) prohibits two proposed U.S. defense sales to Egypt under the Arms Export Control Act. It specifically blocks the sale of 168 RIM-116C missiles and related support (from Transmittal 20-81) and four MK 49 RAM missile launching systems plus support equipment (from Transmittal 21-0M). The resolution directly affects the U.S. government's ability to proceed with these specific military transactions. If passed, it would prevent the sale of these defense articles and services to the Egyptian government.
Securing Our Students Act This bill authorizes local educational agencies and nonpublic schools to use certain COVID-19 emergency relief funds, services, or assistance for school safety uses, that is improving school conditions for student learning by planning and designing school buildings and facilities, installing infrastructure, providing safety education, and implementing technology or other measures that strengthen security on school premises.
WHO Withdrawal Act This bill requires the President to immediately withdraw the United States from the World Health Organization (WHO) and prohibits using any federal funds to provide for U.S. participation in the WHO. The bill also repeals the 1948 act authorizing the United States to join the WHO.
This joint resolution directs the President to remove U.S. Armed Forces from hostilities against the Houthis in Yemen within 30 days of the enactment of this joint resolution unless Congress authorizes a later withdrawal date, issues a declaration of war, or specifically authorizes the use of the Armed Forces. Prohibited activities include sharing intelligence or providing logistical support to enable offensive strikes by the coalition led by Saudi Arabia. This joint resolution shall not affect any military operations directed at Al Qaeda or associated forces.
Defending Freedom of Conscience for Cadets and Midshipmen Act of 2022 This bill provides that a cadet or midshipman at a federal service academy (e.g., the U.S. Naval Academy) may not be required to be vaccinated for COVID-19 as a condition for graduation and may not be dismissed from the academy as a result of refusing to be vaccinated. Cadets and midshipmen who are prohibited from fulfilling their service agreement due to their refusal to receive a COVID-19 vaccination may not be subjected to repayment provisions (e.g., bonus repayment) or specified debt repayment collections.
SJRES 48 is a joint resolution that would block a specific proposed U.S. military sale to Egypt. It prohibits the sale of certain defense articles and services, including 5,000 TOW 2A RF missiles (model BGM-71E-4B-RF) and related support equipment, as detailed in a transmittal published May 25, 2022. The resolution directly affects the U.S. government's ability to authorize this particular foreign military sale under the Arms Export Control Act. It does not change general policy but targets this specific transaction for congressional disapproval.
Increasing Transparency in Generic Drug Applications Act This bill requires the Food and Drug Administration to inform generic drug applicants, upon request or during review, whether the drug is qualitatively and quantitatively the same as the listed brand-name drug (and if not, the reasons why).
Stopping Home Office Work's Unproductive Problems Act of 2022 or the SHOW UP Act of 2022 This bill requires each executive agency to reinstate the telework policies that were in place on December 31, 2019. Agencies may not implement expanded telework policies unless the Office of Personnel Management certifies that such policies, among other requirements, will have a positive effect on the agency's mission and operational costs.
Freedom to Import Infant Formula Act of 2022 This bill provides duty-free treatment to infant formula. The bill prohibits U.S. Customs and Border Protection from seizing or enforcing restrictions on the importation of infant formula from specified countries (e.g., Canada and the United Kingdom) if the formula meets the legal requirements for sale in that country. The bill also deems formula imported under the bill's provisions to be in compliance with section 412 of the Federal Food, Drug, and Cosmetic Act, which contains requirements related to infant formula manufacturing practices and nutrients.
Babies Need More Formula Now Act of 2022 This bill addresses the regulation of infant formula, including by authorizing the Food and Drug Administration (FDA) to waive certain requirements related to importation. The FDA may waive labeling requirements related to the importation (or distribution or sale) of infant formula from a country with requirements that provide a similar assurance of safety as U.S. requirements. The FDA must, when appropriate, enter into arrangements to harmonize U.S. regulatory requirements pertaining to infant formula with the requirements of other nations. The bill imposes time lines for the FDA to respond to submissions for market approval for new infant formula. The FDA must also issue guidance as to what types of changes in the ingredients of infant formula, if any, may not require a new growth study to meet FDA requirements. The bill also authorizes a person to import, without prior notice to the FDA, up to a three-month supply of infant formula for personal use from a country with formula safety standards similar to U.S. standards, such as Canada. Before recommending or requiring a recall of infant formula due exclusively to a labeling deficiency, the FDA must ensure that the recall will not negatively affect the supply of formula in the United States. The bill also requires the FDA to (1) notify Congress no later than 24 hours after initiating a formula recall, and (2) provide certain information to formula manufacturers about restarting production after an inspection of a manufacturing facility impacted by a recall.
American Sovereignty Restoration Act of 2022 This bill directs the President to terminate U.S. membership in the United Nations (U.N.) and all affiliated bodies. It also ends U.S. participation in all U.N. conventions and agreements. Funds may be appropriated to facilitate U.S. withdrawal from the U.N. No funds may be made available for contributions or payments to any U.N. body. No member of the U.S. Armed Forces may serve under U.N. command, and no funds may be used to support U.S. Armed Forces participation in U.N. military or peacekeeping operations. The bill also repeals diplomatic immunity for officers and employees of the U.N. and for officers and employees of foreign government missions to the U.N. The bill repeals various acts related to the U.N., including the United Nations Participation Act of 1945, the United Nations Headquarters Agreement Act, the United Nations Environment Program Participation Act of 1973, and joint resolutions establishing U.S. membership in the World Health Organization and the U.N. Educational, Scientific, and Cultural Organization.
